FDA grants tentative approval for RIFAXIMIN from MYLAN PHARMACEUTICALS INC FDA Approval Jan. 09, 2026, 17:15 UTC Tentative approval of ANDA #ANDA #219687 for RIFAXIMIN. Decision date: 01/07/2026 Full text
There are no comments here yet...